368 related articles for article (PubMed ID: 10369660)
21. Generation of genuine prion infectivity by serial PMCA.
Weber P; Giese A; Piening N; Mitteregger G; Thomzig A; Beekes M; Kretzschmar HA
Vet Microbiol; 2007 Aug; 123(4):346-57. PubMed ID: 17493773
[TBL] [Abstract][Full Text] [Related]
22. Detection, quantification, and glycotyping of prion protein in specifically activated enzyme-linked immunosorbent assay plates.
Triantaphyllidou IE; Sklaviadis T; Vynios DH
Anal Biochem; 2006 Dec; 359(2):176-82. PubMed ID: 17092479
[TBL] [Abstract][Full Text] [Related]
23. Acute formation of protease-resistant prion protein does not always lead to persistent scrapie infection in vitro.
Vorberg I; Raines A; Priola SA
J Biol Chem; 2004 Jul; 279(28):29218-25. PubMed ID: 15133048
[TBL] [Abstract][Full Text] [Related]
24. Generation of monoclonal antibody that distinguishes PrPSc from PrPC and neutralizes prion infectivity.
Horiuchi M; Karino A; Furuoka H; Ishiguro N; Kimura K; Shinagawa M
Virology; 2009 Nov; 394(2):200-7. PubMed ID: 19766283
[TBL] [Abstract][Full Text] [Related]
25. Octapeptide repeat insertions increase the rate of protease-resistant prion protein formation.
Moore RA; Herzog C; Errett J; Kocisko DA; Arnold KM; Hayes SF; Priola SA
Protein Sci; 2006 Mar; 15(3):609-19. PubMed ID: 16452616
[TBL] [Abstract][Full Text] [Related]
26. Screening a library of potential prion therapeutics against cellular prion proteins and insights into their mode of biological activities by surface plasmon resonance.
Touil F; Pratt S; Mutter R; Chen B
J Pharm Biomed Anal; 2006 Mar; 40(4):822-32. PubMed ID: 16242887
[TBL] [Abstract][Full Text] [Related]
27. Binding of neural cell adhesion molecules (N-CAMs) to the cellular prion protein.
Schmitt-Ulms G; Legname G; Baldwin MA; Ball HL; Bradon N; Bosque PJ; Crossin KL; Edelman GM; DeArmond SJ; Cohen FE; Prusiner SB
J Mol Biol; 2001 Dec; 314(5):1209-25. PubMed ID: 11743735
[TBL] [Abstract][Full Text] [Related]
28. PrP(Sc) of scrapie 263K propagates efficiently in spleen and muscle tissues with protein misfolding cyclic amplification.
Shi S; Dong CF; Wang GR; Wang X; An R; Chen JM; Shan B; Zhang BY; Xu K; Shi Q; Tian C; Gao C; Han J; Dong XP
Virus Res; 2009 Apr; 141(1):26-33. PubMed ID: 19162101
[TBL] [Abstract][Full Text] [Related]
29. A conformational transition at the N terminus of the prion protein features in formation of the scrapie isoform.
Peretz D; Williamson RA; Matsunaga Y; Serban H; Pinilla C; Bastidas RB; Rozenshteyn R; James TL; Houghten RA; Cohen FE; Prusiner SB; Burton DR
J Mol Biol; 1997 Oct; 273(3):614-22. PubMed ID: 9356250
[TBL] [Abstract][Full Text] [Related]
30. The use of monoclonal antibody epitopes for tagging PrP in conversion experiments.
Vorberg I; Pfaff E; Groschup MH
Arch Virol Suppl; 2000; (16):285-90. PubMed ID: 11214932
[TBL] [Abstract][Full Text] [Related]
31. Effect of glycosylphosphatidylinositol anchor-dependent and -independent prion protein association with model raft membranes on conversion to the protease-resistant isoform.
Baron GS; Caughey B
J Biol Chem; 2003 Apr; 278(17):14883-92. PubMed ID: 12594216
[TBL] [Abstract][Full Text] [Related]
32. Comparison of protease-resistant prion protein inhibitors in cell cultures infected with two strains of mouse and sheep scrapie.
Kocisko DA; Engel AL; Harbuck K; Arnold KM; Olsen EA; Raymond LD; Vilette D; Caughey B
Neurosci Lett; 2005 Nov; 388(2):106-11. PubMed ID: 16039063
[TBL] [Abstract][Full Text] [Related]
33. Differential solubility of prions is associated in manifold phenotypes.
Kuczius T; Karch H; Groschup MH
Mol Cell Neurosci; 2009 Nov; 42(3):226-33. PubMed ID: 19607920
[TBL] [Abstract][Full Text] [Related]
34. Truncated PrP(c) in mammalian brain: interspecies variation and location in membrane rafts.
Laffont-Proust I; Hässig R; Haïk S; Simon S; Grassi J; Fonta C; Faucheux BA; Moya KL
Biol Chem; 2006 Mar; 387(3):297-300. PubMed ID: 16542151
[TBL] [Abstract][Full Text] [Related]
35. Charged bipolar suramin derivatives induce aggregation of the prion protein at the cell surface and inhibit PrPSc replication.
Nunziante M; Kehler C; Maas E; Kassack MU; Groschup M; Schätzl HM
J Cell Sci; 2005 Nov; 118(Pt 21):4959-73. PubMed ID: 16219680
[TBL] [Abstract][Full Text] [Related]
36. Expression of PrP(C) as HIS-fusion form in a baculovirus system and conversion of expressed PrP-sen to PrP-res in a cell-free system.
Zhang FP; Zhang J; Zhou W; Zhang BY; Hung T; Dong XP
Virus Res; 2002 Aug; 87(2):145-53. PubMed ID: 12191778
[TBL] [Abstract][Full Text] [Related]
37. Detection of prion epitopes on PrP and PrP of transmissible spongiform encephalopathies using specific monoclonal antibodies to PrP.
Yuan FF; Biffin S; Brazier MW; Suarez M; Cappai R; Hill AF; Collins SJ; Sullivan JS; Middleton D; Multhaup G; Geczy AF; Masters CL
Immunol Cell Biol; 2005 Dec; 83(6):632-7. PubMed ID: 16266315
[TBL] [Abstract][Full Text] [Related]
38. The octarepeat region of the prion protein is conformationally altered in PrP(Sc).
Yam AY; Gao CM; Wang X; Wu P; Peretz D
PLoS One; 2010 Feb; 5(2):e9316. PubMed ID: 20195363
[TBL] [Abstract][Full Text] [Related]
39. Differential immunoreactivity of goat derived scrapie following in vitro misfolding versus mouse bioassay.
Madsen-Bouterse SA; Zhuang D; O'Rourke KI; Schneider DA
Biochem Biophys Res Commun; 2012 Jul; 423(4):770-4. PubMed ID: 22713450
[TBL] [Abstract][Full Text] [Related]
40. Synergistic and strain-specific effects of bovine spongiform encephalopathy and scrapie prions in the cell-free conversion of recombinant prion protein.
Eiden M; Palm GJ; Hinrichs W; Matthey U; Zahn R; Groschup MH
J Gen Virol; 2006 Dec; 87(Pt 12):3753-3761. PubMed ID: 17098995
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
